What does Cannabinol (CBN) do?

Minor cannabis compound marketed for sleep, but clinical trials show little benefit beyond placebo.

Is Cannabinol (CBN) safe?

Clinical trials show CBN does not significantly outperform placebo for sleep — the core marketing claim is not supported

Cannabinol (CBN) - Science-Based Research

What the Science Says

Cannabinol (CBN) is a minor cannabinoid found naturally in the cannabis plant, formed as THC degrades over time. It is marketed primarily as a sleep aid, and two randomized controlled trials tested it for sleep disturbance. One trial found no significant improvement in sleep quality with 20 mg CBN compared to placebo over 7 nights. A larger trial found that adding low-dose CBN to CBD or melatonin formulas did not improve sleep outcomes beyond those ingredients alone. One animal study suggests CBN may reduce voluntary alcohol consumption, and lab studies show it can inhibit pain-related nerve signals, but neither finding has been tested in humans.

What It Doesn't Do

Not proven to help you fall asleep faster or stay asleep longer — clinical trials show it doesn't outperform placebo on its own. Adding CBN to CBD or melatonin products doesn't make them work better. No human evidence it relieves pain. Not a proven treatment for alcohol use disorder. The 'sedating cannabinoid' claim is largely marketing, not science.

Evidence-Based Benefits

Cannabinol (CBN) is a minor cannabinoid found naturally in the cannabis plant, formed as THC degrades over time. It is marketed primarily as a sleep aid, and two randomized controlled trials tested it for sleep disturbance. One trial found no significant improvement in sleep quality with 20 mg CBN compared to placebo over 7 nights. A larger trial found that adding low-dose CBN to CBD or melatonin formulas did not improve sleep outcomes beyond those ingredients alone. One animal study suggests CBN may reduce voluntary alcohol consumption, and lab studies show it can inhibit pain-related nerve signals, but neither finding has been tested in humans.

Weak Evidence

Effective at: No established dose from provided studies

Source: auto-research

Absorption & Bioavailability

Unknown — no dedicated bioavailability studies for CBN were provided. Pharmacokinetic data from cannabis smoking studies show CBN appears in oral fluid and plasma but is often undetected after oral dosing, suggesting variable or poor oral absorption.

Red Flags to Watch For

Clinical trials show CBN does not significantly outperform placebo for sleep — the core marketing claim is not supported
At mid-to-high doses (3–4.7 µM), CBN showed signs of liver toxicity in a human liver chip model, including morphological changes
CBN appears in unregulated vaping and hemp-derived combination products that may contain unlabeled or harmful additives
64 registered supplement products contain CBN despite very limited clinical evidence — widespread commercial use is far ahead of the science
Animal data on alcohol reduction and pain relief has not been replicated in human trials

Research Sources

PubMed
NIH DSLD